Creative Medical Technology Holdings (CELZ) Receivables (2017 - 2021)

Creative Medical Technology Holdings (CELZ) has reported Receivables for 5 consecutive years, with $2485.0 the latest figure, recorded in Q4 2021.

• On a quarterly basis, Receivables changed N/A year-over-year to $2485.0 in Q4 2021; TTM through Dec 2021 was $2485.0, a N/A change from a year earlier, with the FY2021 full-year figure at $2485.0, changed N/A from the prior year.
• Receivables was $2485.0 for Q4 2021 at Creative Medical Technology Holdings, up from $1400.0 in the prior quarter.
• Over five years, Receivables peaked at $24500.0 in Q3 2019 and troughed at $163.0 in Q1 2019.
• A 5-year average of $7195.8 and a median of $5200.5 in 2017 frame the typical range for Receivables.
• Across the five-year window, Receivables plunged 98.3% in 2019 and soared 5053.37% in 2020, its largest moves.
• Over 5 years, Receivables stood at $4801.0 in 2017, then jumped by 99.96% to $9600.0 in 2018, then sank by 41.67% to $5600.0 in 2019, then slumped by 75.0% to $1400.0 in 2020, then soared by 77.5% to $2485.0 in 2021.
• The last three Receivables figures came in at $2485.0 (Q4 2021), $1400.0 (Q2 2020), and $8400.0 (Q1 2020), per Business Quant data.